EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Fibroblast Activation Protein Inhibitor PET Imaging in Head and Neck Cancer

Manuel Röhrich

PET Clinics · 2023

DOI: 10.1016/j.cpet.2023.02.002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift PET Clinics, 2023. Verfasst von Manuel Röhrich. Beteiligte Einrichtung: Department of Nuclear Medicine, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany. Electronic address: manuel.roehrich@med.uni-heid…. Hauptthemen laut MEDLINE: Neoplasms, Unknown Primary, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

68Ga-fibroblast activation protein inhibitor (FAPI)-PET is highly promising for head and neck cancers including oral squamous cell carcinomas, hypopharynx carcinomas, adenoid cystic carcinomas, thyroid cancer, and cervical cancer of unknown primary. For oral squamous cell carcinomas, hypopharynx carcinomas, and adenoid cystic carcinomas, 68Ga-FAPI-PET has high potential for the assessment of primary tumors with impact on radiotherapy planning. 68Ga-FAPI-PET can be applied for staging of metastasized thyroid carcinomas. To date, the data on cervical cancer of unknown primary are sparse but highly interesting as 68Ga-FAPI-PET may detect a significant portion of 18fluoro-deoxyglucose-PET-negative primary tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasms, Unknown PrimaryUterine Cervical NeoplasmsHead and Neck NeoplasmsCarcinoma, Squamous CellHumansFemaleSquamous Cell Carcinoma of Head and NeckGallium RadioisotopesFibroblastsPositron Emission Tomography Computed TomographyFluorodeoxyglucose F18

Stichwörter der Autor:innen

ACCAdenoid cystic carcinomaFAPI-PETHead and neck cancerHypopharynx carcinomasOral squamous cell carcinomasPETThyroid cancer

Substanzen

Gallium RadioisotopesFluorodeoxyglucose F18

Autor:innen und Institutionen

  • Department of Nuclear Medicine, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany. Electronic address: manuel.roehrich@med.uni-heidelberg.de.

Zitieren

APA

Röhrich, M. (2023). Fibroblast Activation Protein Inhibitor PET Imaging in Head and Neck Cancer. PET Clinics. https://doi.org/10.1016/j.cpet.2023.02.002

Vancouver

Röhrich M. Fibroblast Activation Protein Inhibitor PET Imaging in Head and Neck Cancer. PET Clinics. 2023. doi:10.1016/j.cpet.2023.02.002

BibTeX
@article{Rhrich2023,
  author = {Röhrich, Manuel},
  title = {Fibroblast Activation Protein Inhibitor PET Imaging in Head and Neck Cancer},
  journal = {PET Clinics},
  year = {2023},
  doi = {10.1016/j.cpet.2023.02.002}
}
Kostenlos starten →